Title
Antidepressant for the prevention of DEPression following first episode Psychosis trial (ADEPP)
Objectives
To establish the effectiveness and cost-effectiveness of an antidepressant medication (sertraline) for the prevention of a depressive episode following first episode psychosis (FEP).
Trial Design
Multi-centre randomised, double-blind, placebo controlled trial with an internal pilot study.
Participant Population and Sample Size
508 participants will be recruited from Early Intervention in Psychosis services in England and Wales within 3 months of FEP treatment onset.
Primary outcome measure
The primary outcome will be the number of new cases of depression as indicated by a CDSS score >5 and confirmed by MINI diagnostic interview in each treatment arm over the 6-month intervention phase.